DEVS vs SRPT
DevvStream Corp. Common Stock (DEVS) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
DevvStream Corp. Common Stock (DEVS) is a pollution & treatment controls company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported DEVS revenue for 2025-07-31 was $25.8K. Net income was -$12.1M. DEVS currently screens at market cap $13.4M.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
DEVS currently screens at market cap $13.4M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the DEVS and SRPT stock pages for the full models.
Not investment advice.